| pubmed-article:19111014 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19111014 | lifeskim:mentions | umls-concept:C2347026 | lld:lifeskim |
| pubmed-article:19111014 | lifeskim:mentions | umls-concept:C0370003 | lld:lifeskim |
| pubmed-article:19111014 | lifeskim:mentions | umls-concept:C0015316 | lld:lifeskim |
| pubmed-article:19111014 | lifeskim:mentions | umls-concept:C0238711 | lld:lifeskim |
| pubmed-article:19111014 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:19111014 | pubmed:dateCreated | 2009-1-5 | lld:pubmed |
| pubmed-article:19111014 | pubmed:abstractText | Administrative data from the Australian Pharmaceutical Benefits Scheme (PBS) showed rapid growth of esomeprazole dispensing when it was launched. Australia has universal prescription medicine coverage (the PBS), which included esomeprazole from August 2002. Free samples of new medicines are commonly provided to doctors. | lld:pubmed |
| pubmed-article:19111014 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19111014 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19111014 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19111014 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19111014 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19111014 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19111014 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19111014 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:19111014 | pubmed:issn | 1099-1557 | lld:pubmed |
| pubmed-article:19111014 | pubmed:author | pubmed-author:TettSusan ESE | lld:pubmed |
| pubmed-article:19111014 | pubmed:author | pubmed-author:NissenLisa... | lld:pubmed |
| pubmed-article:19111014 | pubmed:author | pubmed-author:KyleGregory... | lld:pubmed |
| pubmed-article:19111014 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19111014 | pubmed:volume | 18 | lld:pubmed |
| pubmed-article:19111014 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19111014 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19111014 | pubmed:pagination | 62-8 | lld:pubmed |
| pubmed-article:19111014 | pubmed:meshHeading | pubmed-meshheading:19111014... | lld:pubmed |
| pubmed-article:19111014 | pubmed:meshHeading | pubmed-meshheading:19111014... | lld:pubmed |
| pubmed-article:19111014 | pubmed:meshHeading | pubmed-meshheading:19111014... | lld:pubmed |
| pubmed-article:19111014 | pubmed:meshHeading | pubmed-meshheading:19111014... | lld:pubmed |
| pubmed-article:19111014 | pubmed:meshHeading | pubmed-meshheading:19111014... | lld:pubmed |
| pubmed-article:19111014 | pubmed:meshHeading | pubmed-meshheading:19111014... | lld:pubmed |
| pubmed-article:19111014 | pubmed:meshHeading | pubmed-meshheading:19111014... | lld:pubmed |
| pubmed-article:19111014 | pubmed:meshHeading | pubmed-meshheading:19111014... | lld:pubmed |
| pubmed-article:19111014 | pubmed:meshHeading | pubmed-meshheading:19111014... | lld:pubmed |
| pubmed-article:19111014 | pubmed:meshHeading | pubmed-meshheading:19111014... | lld:pubmed |
| pubmed-article:19111014 | pubmed:meshHeading | pubmed-meshheading:19111014... | lld:pubmed |
| pubmed-article:19111014 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19111014 | pubmed:articleTitle | The Australian rise of esomeprazole-was expenditure on samples a contributor? | lld:pubmed |
| pubmed-article:19111014 | pubmed:affiliation | School of Pharmacy, The University of Queensland, Brisbane, Queensland 4072, Australia. g.kyle1@uq.edu.au | lld:pubmed |
| pubmed-article:19111014 | pubmed:publicationType | Journal Article | lld:pubmed |
